Neurological phenotype of Potocki-Lupski syndrome.
Claudia CiaccioChiara PantaleoniDonatella MilaniEnrico AlfeiFrancesca L SciaccaLaura CanafogliaAlessandra ErbettaStefano D'ArrigoPublished in: American journal of medical genetics. Part A (2020)
Potocki-Lupski syndrome is a condition mainly characterized by infantile hypotonia, developmental delay/intellectual disability (DD/ID), and congenital anomalies, caused by duplications of the 17p11.2 region, encompassing RAI1 gene. Its clinical presentation is extremely variable, especially for what concerns the cognitive level and the behavioral phenotype. Such aspects, as well as the dysmorphic/malformative ones, have been covered by previous studies; otherwise neurological features have never been systematically described. In order to delineate the neurological phenotype of Potocki-Lupski Syndrome, we collect an 8-patients cohort. Developmental milestones are delayed and a mild to moderate cognitive impairment is present in all patients, variably associated with features of autism spectrum disorder, behavioral disturb, and sleep disturb. Hypotonia appears a less frequent finding than what previously reported, while motor clumsiness/coordination impairment is frequent. EGG registration demonstrated a common pattern with excess of diffuse rhythmic activity in sleep phases or while the patient is falling asleep. Brain MRI did not reveal common anomalies, although unspecific white matter changes may be present. We discuss such findings and compare them to literature data, offering an overview on the neurological and cognitive-behavioral presentation of the syndrome.
Keyphrases
- autism spectrum disorder
- intellectual disability
- case report
- end stage renal disease
- white matter
- ejection fraction
- chronic kidney disease
- newly diagnosed
- cognitive impairment
- prognostic factors
- magnetic resonance imaging
- systematic review
- gene expression
- patient reported outcomes
- multiple sclerosis
- computed tomography
- cerebral ischemia
- depressive symptoms
- attention deficit hyperactivity disorder
- genome wide
- sleep quality
- contrast enhanced
- diffusion weighted imaging
- blood brain barrier
- magnetic resonance
- artificial intelligence
- big data
- patient reported
- genome wide identification